Cargando…
PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
SIMPLE SUMMARY: Cancer is a major public health problem worldwide, and addressing its morbidity, mortality, and prevalence is the first step towards appropriate control measures. Over the past several decades, many pharmacologists have worked to identify anti-cancer targets and drug development stra...
Autores principales: | Huang, Hai, Lee, Mee-Hyun, Liu, Kangdong, Dong, Zigang, Ryoo, Zeayoung, Kim, Myoung Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124186/ https://www.ncbi.nlm.nih.gov/pubmed/34066486 http://dx.doi.org/10.3390/cancers13092232 |
Ejemplares similares
-
PBK/TOPK: A Therapeutic Target Worthy of Attention
por: Han, Ziping, et al.
Publicado: (2021) -
PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022) -
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016) -
PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015) -
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)